<DOC>
	<DOC>NCT02776046</DOC>
	<brief_summary>The iPROVE-O2 trial aims at comparing the efficacy of high and conventional FiO2 within a perioperative individualized ventilatory strategy to reduce the overall incidence of SSI.</brief_summary>
	<brief_title>Individualized Perioperative Open-lung Ventilatory Strategy With High Versus Conventional Inspiratory Oxygen Fraction (iPROVE-O2).</brief_title>
	<detailed_description />
	<mesh_term>Postoperative Complications</mesh_term>
	<mesh_term>Surgical Wound Infection</mesh_term>
	<mesh_term>Hyperoxia</mesh_term>
	<criteria>Age not less than 18 Planned abdominal surgery&gt; 2 hours. Signed informed consent for participation in the study. Age less than 18 years. Pregnant or breastfeeding. Patients with BMI &gt;35. Syndrome of moderate or severe respiratory distress: PaO2/FiO2 &lt; 200 mmHg. Heart failure: NYHA IV. Hemodynamic failure: CI &lt;2.5 L/min/m2 and / or requirements before surgery ionotropic support. Diagnosis or suspicion of intracranial hypertension (intracranial pressure&gt; 15 mmHg). Mechanical ventilation in the last 15 days. Presence of pneumothorax. Presence of giant bullae on chest radiography or computed tomography (CT). Patient with preoperatively CPAP. Participation in another experimental protocol at the time of intervention selection.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Oxygen, surgical site infection, postoperative complication, recruitment maneuvers, open lung strategy</keyword>
</DOC>